Skip to main content
. 2024 Oct 24;14(46):33820–33829. doi: 10.1039/d4ra03267e

Fig. 2. Schematic of the synthesis of the quinazolinone based SARS-CoV-2 3CL protease inhibitor. Synthesis of febrifugine analogues (Scheme 1) (a: Zn, CH3COONH4, MeOH, 83%) and quinazolinone conjugated benzimidazole (Scheme 2).

Fig. 2